Search results for "SPN"

showing 10 items of 90 documents

Mediastinal syndrome from plasmablastic lymphoma in human immunodeficiency virus and human herpes virus 8 negative patient with polycythemia vera: a …

2017

Background: Plasmoblastic lymphoma is a rare and aggressive subtype of diffuse large B cell lymphoma, which occurs usually in the jaw of immunocompromised subjects. Case presentation: We describe the occurrence of plasmoblastic lymphoma in the mediastinum and chest wall skin of an human immunodeficiency virus-negative 63-year-old Caucasian man who had had polycytemia vera 7 years before. At admission, the patient showed a superior vena cava syndrome, with persistent dyspnoea, cough, and distension of the jugular veins. Imaging findings showed a 9.7 × 8 × 5.7 cm mediastinal mass. A chest wall neoformation biopsy and ultrasound-guided fine-needle aspiration biopsy of the mediastinal mass allo…

MalePathologySettore MED/21 - Chirurgia ToracicaCase ReportSettore MED/15 - Malattie Del Sangue0302 clinical medicinePolycythemia veraPolycythemia VeraCase report; Fine-needle aspiration biopsy; Hematology; Rare clinical case; Thoracic surgery; Medicine (all)UltrasonographyMedicine(all)Rare clinical caseSuperior vena cava syndromeHematologymedicine.diagnostic_testMedicine (all)MediastinumMediastinumGeneral MedicineHematologyHerpesviridae InfectionsSyndromeMiddle AgedThoracic surgerymedicine.anatomical_structureTreatment Outcome030220 oncology & carcinogenesisHerpesvirus 8 HumanPlasmablastic Lymphomamedicine.symptommedicine.medical_specialtyBiopsy Fine-NeedleMediastinal Neoplasms03 medical and health sciencesInternal medicineHIV SeronegativityBiopsymedicineHumansbusiness.industryThrombosisFine-needle aspiration biopsymedicine.diseaseLymphomaSettore MED/18 - Chirurgia GeneraleDyspneaCoughJugular VeinsbusinessDiffuse large B-cell lymphomaPlasmablastic lymphoma030215 immunology
researchProduct

Epidemiology and Characteristics of Episodic Breathlessness in Advanced Cancer Patients. An Observational Study

2016

Abstract Context Episodic breathlessness is a relevant aspect in patients with advanced cancer. Objectives The aim of this study was to assess the different aspects of this clinical phenomenon. Methods A consecutive sample of patients with advanced cancer admitted to different settings for a period of six months was surveyed. The presence of background breathlessness and episodic breathlessness, their intensity (numerical scale 0–10), and drugs used for treatment were collected. Factors inducing episodic breathlessness and its influence on daily activities were investigated. Results Of 921 patients, 29.3% ( n  = 269) had breathlessness and 134 patients (49.8%) were receiving drugs for backg…

MalePediatricsmedicine.medical_specialtyPalliative careActivities of daily livingTime FactorsEpisodic breathlessneSettore MED/41 - AnestesiologiaContext (language use)advanced cancer; dyspnea; Episodic breathlessness; opioids; palliative care; Anesthesiology and Pain Medicine; Neurology (clinical); Nursing (all)2901 Nursing (miscellaneous)DiseaseComorbidityepisodic breathlessness; advanced cancer; dyspnea; opioids; palliative care03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineNeoplasmsEpidemiologyActivities of Daily LivingmedicinePrevalenceHumansadvanced cancer030212 general & internal medicineKarnofsky Performance StatusGeneral NursingNursing (all)2901 Nursing (miscellaneous)Agedpalliative careEpisodic breathlessnessbusiness.industryEpisodic breathlessness; advanced cancer; dyspnea; opioids; palliative careopioidsCardiovascular Agentsrespiratory systemMiddle Ageddyspneamedicine.diseaseComorbidityAnesthesiology and Pain Medicine030220 oncology & carcinogenesisCardiovascular agentMultivariate AnalysisopioidObservational studyFemaleNeurology (clinical)business
researchProduct

Indacaterol vs tiotropium in COPD patients classified as GOLD A and B

2015

SummaryIntroductionAccording to current GOLD strategy, patients with COPD classified as groups A and B may be treated with inhaled bronchodilators, either long-acting β2-agonist (LABA) or long-acting muscarinic antagonist (LAMA). However, there is little guidance on which class of agent is preferred and a lack of prospective data to differentiate the two.MethodsIn this study, we performed post-hoc analyses of pooled data from two prospective, controlled clinical trials comparing the LABA indacaterol and LAMA tiotropium in 1422 patients with moderate airflow limitation and no history of exacerbations in the previous year. This population fits the definitions of GOLD A and B groups and could …

MalePulmonary and Respiratory MedicineEfficacyPopulationINDEXESQuinolonesOBSTRUCTIVE PULMONARY-DISEASEPulmonary Disease Chronic ObstructiveHumansMedicineCOPDCOHORTProspective StudiesGOLDTiotropium BromideeducationDYSPNEAIndacateroleducation.field_of_studyCOPDDose-Response Relationship Drugbiologybusiness.industryTiotropiumONCE-DAILY INDACATEROLMuscarinic antagonistForced Expiratory Flow RatesBaseline Dyspnea IndexMiddle AgedLamabiology.organism_classificationmedicine.diseaseBronchodilator Agentsrespiratory tract diseasesClinical trialTreatment OutcomeAnesthesiaIndansCohortIndacaterolFemalebusinessCLINICAL METHODSFollow-Up Studiesmedicine.drugRespiratory Medicine
researchProduct

Patterns and predictors of low physical activity in patients with stable COPD: a longitudinal study

2020

Background: Despite the frequency and negative impact of low physical activity among patients with chronic obstructive pulmonary disease (COPD), little is known about how it persists and remits over time or the factors predicting new states of low physical activity. The aim of the study was to determine the probability of a transition between states of low and nonlow physical activity in a cohort of patients with stable COPD followed for 2 years. We also investigated different potentially modifiable factors to determine whether they can predict new states of low physical activity. Methods: We prospectively included 137 patients with stable COPD (mean age 66.9 ± 8.3 years). Physical activity…

MalePulmonary and Respiratory MedicineLongitudinal studymedicine.medical_specialtyTime FactorsHealth StatusPhysical activityphysical activityPulmonary diseasePulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineCOPDHumansMedicinePharmacology (medical)In patientLongitudinal StudiesProspective Studies030212 general & internal medicineExerciseLungOriginal ResearchAgedlcsh:RC705-779COPDbusiness.industrytransitionlcsh:Diseases of the respiratory systemdyspneaMiddle AgedPrognosismedicine.disease5STS030228 respiratory systemDisease ProgressionFemaleSedentary BehaviorbusinessTherapeutic Advances in Respiratory Disease
researchProduct

The ‘real-life’ COPD patient in Germany: The DACCORD study

2016

Abstract Introduction DACCORD is an ongoing, longitudinal, non-interventional study within the German COPD National Prospective Registry. This manuscript describes the baseline characteristics of the first 5924 participants, recruited between November 2012 and November 2013. Methods The main inclusion criteria are a physician diagnosis of COPD, age ≥40 years, and initiating or changing COPD maintenance medication. Data collected included: Demographic and disease characteristics; prescribed medication; symptoms; COPD Assessment Test (CAT); modified Medical Research Council dyspnoea score (mMRC); exacerbations; comorbidities; and forced expiratory volume in 1 s (FEV 1 ). Results Approximately…

MalePulmonary and Respiratory MedicineRegistryPediatricsmedicine.medical_specialtyPopulationComorbiditySeverity of Illness IndexPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineBaselineForced Expiratory VolumeGermanyCOPDHumansMedicineProspective StudiesRegistries030212 general & internal medicineeducationObservationalAgededucation.field_of_studyCOPDPrimary Health Carebusiness.industryMiddle AgedExertional dyspnoeamedicine.diseaseComorbidityRegimenTreatment Outcome030228 respiratory systemSpirometryBaseline characteristicsFemaleDisease characteristicsObservational studybusinessRespiratory Medicine
researchProduct

Use of a portable device to record maximum inspiratory flow in relation to dyspnoea in patients with COPD

2011

SummaryForced inspiratory measures have been described to reflect the reduction in dyspnoea upon bronchodilation in severe COPD. Based on this we evaluated the applicability and usefulness of a portable device for the assessment of forced inspiration. In 37 patients with COPD (GOLD II/II/IV n = 16/15/6, mean ± SD FEV1 46.2 ± 15.4%pred) lung function was recorded prior to inhalation of 24 μg formoterol and 30 min later. Assessments comprised spirometry including forced inspiration, body plethysmography, maximum inspiratory flow (InCheck, Clement Clarke), and changes in dyspnoea via visual analogue scale (VAS). The sequence was repeated on a second day to assess reproducibility. Bronchodilati…

MalePulmonary and Respiratory MedicineSpirometrymedicine.medical_specialtyPortable deviceVisual analogue scalePeak inspiratory flowPulmonary Disease Chronic ObstructiveForced inspirationInternal medicineDyspnoeaBronchodilationCOPDHumansMedicinePlethysmographPeak flow meterMonitoring Physiologicmeasurement_unitAnalysis of VarianceCOPDmedicine.diagnostic_testbusiness.industrymedicine.diseaserespiratory tract diseasesBronchodilatationDyspneaSpirometrymeasurement_unit.measuring_instrumentPhysical therapyCardiologyBronchodilationFemaleFormoterolbusinessInspiratory Capacitymedicine.drugRespiratory Medicine
researchProduct

The MRC dyspnoea scale by telephone interview to monitor health status in elderly COPD patients

2010

SummaryDyspnoea is the most common symptom associated with poor quality of life in patients affected by Chronic Obstructive Pulmonary Disease (COPD). While COPD severity is commonly staged by lung function, the Medical Research Council (MRC) dyspnoea scale has been proposed as a more clinically meaningful method of quantifying disease severity in COPD. We wished to assess whether this scale might also be useful during telephone surveys as a simple surrogate marker of perceived health status in elderly patients with COPD.We conducted a comprehensive health status assessment by telephone survey of 200 elderly patients who had a physician diagnosis of COPD. The telephone survey contained 71 it…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyActivities of daily livingCopd patientsHealth statusInterviews as TopicPulmonary Disease Chronic ObstructiveQuality of life (healthcare)MRC dyspnoea scaleSurveys and QuestionnairesActivities of Daily LivingEpidemiologymedicineHealth Status IndicatorsHumansCOPDAgedAged 80 and overCOPDbusiness.industrySurrogate endpointrespiratory systemmedicine.diseasehumanitiesrespiratory tract diseasesDyspneaItalyTelephone interviewScale (social sciences)Quality of LifePhysical therapyTelephone surveyFemalebusinessRespiratory Medicine
researchProduct

The COPD multi-dimensional phenotype: A new classification from the STORICO Italian observational study.

2019

BackgroundThis paper is aimed to (i) develop an innovative classification of COPD, multi-dimensional phenotype, based on a multidimensional assessment; (ii) describe the identified multi-dimensional phenotypes.MethodsAn exploratory factor analysis to identify the main classificatory variables and, then, a cluster analysis based on these variables were run to classify the COPD-diagnosed 514 patients enrolled in the STORICO (trial registration number: NCT03105999) study into multi-dimensional phenotypes.ResultsThe circadian rhythm of symptoms and health-related quality of life, but neither comorbidity nor respiratory function, qualified as primary classificatory variables. Five multidimension…

MalePulmonologyPhysiologyComorbidityAnxietyPathology and Laboratory MedicineCohort StudiesPulmonary Disease Chronic ObstructiveMathematical and Statistical TechniquesQuality of lifeMedicine and Health SciencesCoughingCluster AnalysisRespiratory functionPublic and Occupational HealthAged 80 and overCOPDMultidisciplinaryDepressionApplied MathematicsSimulation and ModelingQStatisticsRMiddle AgedExploratory factor analysisCircadian RhythmBody FluidsCircadian RhythmsPhenotypeItalyPhysical SciencesAnxietyMedicineFemalemedicine.symptomAnatomyFactor AnalysisAlgorithmsCohort studyResearch Articlemedicine.medical_specialtyScienceMemory EpisodicChronic Obstructive Pulmonary DiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioResearch and Analysis MethodsClustering AlgorithmsSigns and SymptomsDiagnostic MedicineInternal medicinemedicineCOPDHumansStatistical MethodsAgedbusiness.industryBiology and Life SciencesPhysical Activitymedicine.diseaseComorbidityrespiratory tract diseasesMucusDyspneaCoughQuality of LifeObservational studybusinessFactor Analysis StatisticalSleepPhysiological ProcessesChronobiologymultiple phenotypesMathematicsPloS one
researchProduct

Use of high flow nasal cannula in patients with acute respiratory failure in general wards under intensivists supervision: a single center observatio…

2022

Abstract Background Few data exist on high flow nasal cannula (HFNC) use in patients with acute respiratory failure (ARF) admitted to general wards. Rationale and objectives To retrospectively evaluate feasibility and safety of HFNC in general wards under the intensivist-supervision and after specific training. Methods Patients with ARF (dyspnea, respiratory rate-RR > 25/min, 150 < PaO2/FiO2 < 300 mmHg during oxygen therapy) admitted to nine wards of an academic hospital were included. Gas-exchange, RR, and comfort were assessed before HFNC and after 2 and 24 h of application. Results 150 patients (81 male, age 74 [60–80] years, SOFA 4 [2–4]), 123 with de-novo ARF underwent HFNC wi…

MaleRespiratory Distress SyndromeNoninvasive VentilationOxygen Inhalation TherapyARFHFNCOxygenGeneral-wardsDyspneaAHRFICU-supervisionPatients' RoomsCannulaHumansSafetyRespiratory InsufficiencyAgedRetrospective Studies
researchProduct

The Usefulness of Bioelectrical Impedance Analysis in Differentiating Dyspnea Due to Decompensated Heart Failure

2007

Acute dyspnea poses a diagnostic challenge for physicians, and the current methods in differentiating cardiac from non-cardiac causes have been limited to date. Recently, the brain natriuretic peptide (BNP) rapid test has been validated in the emergency room. Nevertheless, the early accumulation of fluid in the interstitial space in the body and in the lungs, which characterizes patients with ADHF, is well estimated by BIA. We investigate whether bioelectrical impedance analysis (BIA) can serve as a noninvasive diagnostic tool in the differential diagnosis of acute decompensated heart failure (ADHF) in the emergency department (ED).A total of 292 patients presenting with acute dyspnea to th…

Malemedicine.medical_specialtyAcute decompensated heart failuremedicine.drug_classSensitivity and SpecificityDiagnosis DifferentialInternal medicineNatriuretic Peptide BrainElectric ImpedancemedicineNatriuretic peptideHospital dischargeHumansIntensive care medicineAgedHeart Failurebusiness.industryEmergency departmentMiddle Agedmedicine.diseaseBrain natriuretic peptideDyspneaROC CurveHeart failureCardiologyFemaleDifferential diagnosisCardiology and Cardiovascular MedicinebusinessBioelectrical impedance analysisAlgorithmsJournal of Cardiac Failure
researchProduct